ReviewFrontiers in immunology2023

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?

Jingyu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.